Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00774137 · ClinicalTrials.gov registry record
Examining New Diagnostic Tests for Acute Kidney Injury After Heart Surgery
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 1,550
- Enrollment target
NCT00774137 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 1,550 participants.
The verdict
NCT00774137 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 1,550 participants
- Enrollment target
Study Summary
People who undergo coronary artery bypass grafting (CABG) or heart valve surgery may experience acute kidney injury (AKI) after their surgery. Current medical tests cannot identify AKI until approximately 48 hours after it occurs. This study will examine three new biomarkers in blood and urine that may provide a more effective and faster way of predicting AKI in people who undergo CABG or heart valve surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,550 participants |
| Start Date | 2007-04 |
| Est. Completion | 2014-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00774137
The ClinicalTrials.gov registry entry for NCT00774137 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00774137 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00774137 about?
NCT00774137 is a clinical study titled "Examining New Diagnostic Tests for Acute Kidney Injury After Heart Surgery". People who undergo coronary artery bypass grafting (CABG) or heart valve surgery may experience acute kidney injury (AKI) after their surgery. Current medical tests cannot identify AKI until approximately 48 hours after it occurs. This study will examine three new biomarkers in blood and urine that ...
What is the current status of trial NCT00774137?
This trial is currently completed. The enrollment target is 1,550 participants. The study started on 2007-04. Estimated completion is 2014-02.
Who is sponsoring clinical trial NCT00774137?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.